Martin-Fardon Lab

Avid runner, tattoo enthusiast, on occasion neuroscientist. The postings are my own and do not necessarily reflect the views of Scripps Research.

[Martin-Fardon Lab @FardonLab]

@brainaddiction Best wishes for a speedy recovery Olivier! You’ll beat this!!!

[Martin-Fardon Lab @FardonLab]

Check out our latest interview:

https://t.co/6yoiaTN3MY

[Martin-Fardon Lab @FardonLab]

https://t.co/9Rk1INjXrB

[Martin-Fardon Lab @FardonLab]

Postdoc position open to study the effects of alcohol/abused substances. Supported by our NIAAA T32. US citizens or permanent residents only. Individuals underrepresented in the field are encouraged to apply. Will attend CPDD and RSA in June 2024. Contact: [email protected]

[Martin-Fardon Lab @FardonLab]

https://t.co/txERdjWjLI

[Martin-Fardon Lab @FardonLab]

https://t.co/txERdjWjLI

[Martin-Fardon Lab @FardonLab]

Postdoc position available to investigate the effects of alcohol and other abused substances. Supported by our NIH/NIAAA T32. US citizens or permanent resident status is required. Individuals underrepresented in the field are encouraged to apply. Contact: [email protected]

[Martin-Fardon Lab @FardonLab]

Postdoc position available to investigate the effects of alcohol and other abused substances. Supported by our NIH/NIAAA T32. US citizens or permanent resident status is required. Individuals underrepresented in the field are encouraged to apply. Contact: [email protected]

[Martin-Fardon Lab @FardonLab]

Research team studies how insomnia treatment could prevent drug relapse https://t.co/5kvkW0BMRG

[Martin-Fardon Lab @FardonLab]

https://t.co/ghueegyja2

[Martin-Fardon Lab @FardonLab]

https://t.co/ghueegyja2

[Scripps Research @scrippsresearch]

A new Scripps Research study shows how an insomnia drug helps prevent oxycodone relapse, paving the way for new therapies. https://t.co/YXpxiUzvbt

[Martin-Fardon Lab @FardonLab]

The title to share https://t.co/j7lSLJH526 #

[Martin-Fardon Lab @FardonLab]

The title to share https://t.co/j7lSLJH526 #

[Dr Melissa Herman @MelissaHerman4]

Fantastic panel focusing on alcohol's effect on the CRF system outside the amygdala (!) Very cool work by Remi Martin-Fardon, @DrJRink Audrey Seasholtz and @superrsema and great moderating by @Marcus

[Marcus Weera @MarcusWeera]

Looking forward to chairing this symposium on CRF-alcohol interactions outside the amygdala with @superrsema at @RSAposts. Come by this Sunday at 1:20 if you can! (1/2)

[Michelle Doyle, PhD @m_r_doyle]

My first postdoc paper from @giodeguglielmo’s is out! We looked at oxycodone effects in 4 rat strains (and both sexes) as part of a collaboration between @TeleseFrancesca, @brainaddiction, @FardonLab labs, and huge effort by lab manager @amaaartinez7 https://t.co/mPwYdsXv1X

[Scripps Research @scrippsresearch]

Scientists in @FardonLab have shown in preclinical studies that the insomnia drug suvorexant is able to reduce prescription opioid intake and help protect against relapse in animals modeling opioid use disorder https://t.co/DapFD2EJMU

[Scripps Research @scrippsresearch]

In a new study by @FardonLab, the team show that the insomnia drug suvorexant, which blocks the activity of brain-cell receptors called orexin receptors, could be repurposed to help reduce voluntary alcohol intake and relapse https://t.co/cuLb9zPtoF @FrontiersIn

[Martin-Fardon Lab @FardonLab]

Our new website is up: https://t.co/4CI45lMzX3